FDA recall D-0791-2022

Glenmark Pharmaceuticals Inc., USA · Class II · drug

Product

Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01

Reason for recall

cGMP deviations

Distribution

USA nationwide

Key facts

Status
Completed
Initiation date
2022-04-25
Report date
2022-05-04
Voluntary/Mandated
Voluntary: Firm initiated
Location
Mahwah, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0791-2022